CVS Health (NYSE:CVS) Price Target Cut to $76.00

CVS Health (NYSE:CVS – Get Free Report) had its target price dropped by research analysts at Wells Fargo & Company from $83.00 to $76.00 in a report released on Monday, Benzinga reports. The firm presently has an “equal weight” rating on the pharmacy operator’s stock. Wells Fargo & Company‘s target price would indicate a potential […]

Leave a Reply

Your email address will not be published.

Previous post Canadian Natural Resources (TSE:CNQ) Reaches New 52-Week High Following Analyst Upgrade
Next post Wells Fargo & Company Trims CVS Health (NYSE:CVS) Target Price to $76.00